These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 30283086

  • 1. CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
    Park S, Lee MS, Gwak J, Choi TI, Lee Y, Ju BG, Kim CH, Oh S.
    Cell Death Dis; 2018 Oct 03; 9(10):1023. PubMed ID: 30283086
    [Abstract] [Full Text] [Related]

  • 2. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H.
    J Hepatol; 2018 Jun 03; 68(6):1203-1213. PubMed ID: 29525529
    [Abstract] [Full Text] [Related]

  • 3. Wnt signalling induces accumulation of phosphorylated β-catenin in two distinct cytosolic complexes.
    Gerlach JP, Emmink BL, Nojima H, Kranenburg O, Maurice MM.
    Open Biol; 2014 Nov 03; 4(11):140120. PubMed ID: 25392450
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
    Wang W, Liu P, Lavrijsen M, Li S, Zhang R, Li S, van de Geer WS, van de Werken HJG, Peppelenbosch MP, Smits R.
    Sci Rep; 2021 Apr 02; 11(1):7470. PubMed ID: 33811251
    [Abstract] [Full Text] [Related]

  • 5. WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway.
    Goto T, Matsuzawa J, Iemura S, Natsume T, Shibuya H.
    FEBS Lett; 2016 May 02; 590(9):1291-303. PubMed ID: 27098453
    [Abstract] [Full Text] [Related]

  • 6. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
    Qiao Y, Wang J, Karagoz E, Liang B, Song X, Shang R, Evert K, Xu M, Che L, Evert M, Calvisi DF, Tao J, Wang B, Monga SP, Chen X.
    Hepatology; 2019 Dec 02; 70(6):2003-2017. PubMed ID: 30737831
    [Abstract] [Full Text] [Related]

  • 7. Alterations of axis inhibition protein 1 (AXIN1) in hepatitis B virus-related hepatocellular carcinoma and overexpression of AXIN1 induces apoptosis in hepatocellular cancer cells.
    Li J, Quan H, Liu Q, Si Z, He Z, Qi H.
    Oncol Res; 2013 Dec 02; 20(7):281-8. PubMed ID: 23879168
    [Abstract] [Full Text] [Related]

  • 8. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
    Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T, Clevers H.
    Cell; 2012 Jun 08; 149(6):1245-56. PubMed ID: 22682247
    [Abstract] [Full Text] [Related]

  • 9. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
    Figeac N, Zammit PS.
    Cell Signal; 2015 Aug 08; 27(8):1652-65. PubMed ID: 25866367
    [Abstract] [Full Text] [Related]

  • 10. Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
    Koyama-Nasu R, Hayashi T, Nasu-Nishimura Y, Akiyama T, Yamanaka R.
    Biochem Biophys Res Commun; 2015 Apr 10; 459(3):411-5. PubMed ID: 25735981
    [Abstract] [Full Text] [Related]

  • 11. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Zhang CZ.
    J Cell Sci; 2017 Sep 15; 130(18):3108-3115. PubMed ID: 28754688
    [Abstract] [Full Text] [Related]

  • 12. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 13. C9orf140, a novel Axin1-interacting protein, mediates the negative feedback loop of Wnt/β-catenin signaling.
    Jiang J, Tang S, Xia J, Wen J, Chen S, Shu X, Huen MSY, Deng Y.
    Oncogene; 2018 May 22; 37(22):2992-3005. PubMed ID: 29531269
    [Abstract] [Full Text] [Related]

  • 14. β-Catenin signaling in hepatocellular carcinoma.
    Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X.
    J Clin Invest; 2022 Feb 15; 132(4):. PubMed ID: 35166233
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
    Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo T, Li L, Lin J, Zhang L.
    Int J Oncol; 2013 Dec 15; 43(6):1951-9. PubMed ID: 24064724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. UCHL5 controls β-catenin destruction complex function through Axin1 regulation.
    Han W, Koo Y, Chaieb L, Keum BR, Han JK.
    Sci Rep; 2022 Mar 07; 12(1):3687. PubMed ID: 35256667
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D receptor is a novel transcriptional regulator for Axin1.
    Jin D, Zhang YG, Wu S, Lu R, Lin Z, Zheng Y, Chen H, Cs-Szabo G, Sun J.
    J Steroid Biochem Mol Biol; 2017 Jan 07; 165(Pt B):430-437. PubMed ID: 27601169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.